Distinct immune responses occur at systemic and mucosal sites [1] [2] [3] . In the systemic immune response, there is a limited role for humoral immunity in controlling intracellular infections. Rather, the cellular immune response, which includes elaboration of cytokines such as interferon (IFN)-g, is critical in controlling intracellular infections [4] [5] [6] . The role of the cellular immune response in intestinal mucosal infections is less well understood.
Cryptosporidiosis caused by the protozoan parasite Cryptosporidium parvum is a common cause of diarrhea worldwide [7] . Cryptosporidiosis has emerged as a common cause of epidemics of waterborne diarrheal illness, of childhood diarrhea in developing countries, and of chronic diarrhea in compromised hosts [7, 8] . The organisms are found within parasito-phorous vacuoles located under the plasma membrane of the intestinal epithelial cells [9, 10] . Infection of immunocompetent persons results in a self-limited diarrheal illness or asymptomatic infection [7, 11] . By contrast, immunocompromised patients may not clear the organism and may develop chronic watery diarrhea, dehydration, biliary tract infection, or death.
Little is known about the immunologic control of C. parvum in the human intestine. In murine models, CD4 T cells play an important role in limiting C. parvum infection, because their depletion or absence results in prolonged infection [12] [13] [14] . Similarly, AIDS patients with low CD4 cell counts usually develop chronic infection. However, in human immunodeficiency virus (HIV)-infected patients with CD4 cell counts 1180/mL, cryptosporidiosis is self-limited [15] [16] [17] . Chronic cryptosporidiosis in advanced HIV infection may also resolve as CD4 cell numbers increase with effective antiretroviral therapy [18, 19] .
IFN-g is critical in controlling murine cryptosporidiosis. Antibody to IFN-g exacerbates infection in immunodeficient mice [12, 13, [20] [21] [22] . Inactivation of the IFN-g gene causes fatal C. parvum infection of C57BL/6 mice, whereas wild type mice develop asymptomatic, self-limited infection [23] . Furthermore, interleukin (IL)-12, the major cytokine controlling the expression of IFN-g, prevented oocyst excretion if given before oocyst challenge of SCID mice [24] .
The role of IFN-g in human infection is less clear. Peripheral blood mononuclear cells (PBMC) from persons who have recovered from cryptosporidiosis produced IFN-g after antigen stimulation in vitro [25, 26] . By contrast, no IFN-g production was produced by PBMC of HIV-infected patients during active cryptosporidiosis [26] . Similarly, chronic cryptosporidiosis developed in a patient with impaired IFN-g production but with no other immune defect [26, 27] . Whether there is intestinal production of IFN-g in human cryptosporidiosis, the timing of expression and its relationship to resolution of infection have not been addressed.
To examine these questions, we used experimental infection of human volunteers [28] [29] [30] [31] . Experimental challenge leads to a spectrum of manifestations, including symptomatic illness with associated oocyst excretion, symptomatic illness without detectable oocyst excretion, or, in some cases, neither symptoms nor oocyst excretion. This model provided the unique opportunity to study cytokine responses in a controlled human infection, with defined baseline serologic status, challenge dose, and clinical and parasitologic responses. AIDS patients with chronic cryptosporidiosis provided a comparison group with uncontrolled infection. We used this model to test for intestinal expression of IFN-g. We then compared the frequency and timing of IFN-g production with prior sensitization as measured by serum antibody, with resistance to infection (as measured by no oocyst excretion following challenge), and with symptoms.
Materials and Methods
Twenty-eight normal volunteers were screened for immunocompetence by measuring serum antibody levels, CD4 and CD8 T cell counts, delayed-type cutaneous hypersensitivity, virus serologies, and medical history [28] [29] [30] [31] . Baseline serum specimens were screened for anti-C. parvum IgG and IgM by ELISA by use of oocyst antigen [28] [29] [30] [31] . Patients were challenged with various doses of C. parvum oocysts as part of ongoing studies aimed at determining the infectious dose of C. parvum [28] [29] [30] [31] . Because seropositive volunteers were more resistant to infection, studies to determine the infectious dose for this group required more organisms than were used to study seronegative volunteers. After challenge, all stools were collected for 2 weeks, and 3 weekly 24-h stool collections were obtained for the subsequent 6 weeks for quantitation of oocyst excretion by direct immunofluorescence. The volunteers recorded all enteric symptoms noted during this period. At various times before or after experimental challenge, patients underwent upper endoscopy with jejunal biopsy (with use of either a pediatric colonoscope or small bowel enteroscope). Three AIDS patients with naturally acquired chronic cryptosporidiosis also volunteered to submit 24-h stool collections and to undergo endoscopy with biopsy.
Biopsy specimens were immediately fixed in diethyl pyrocarbonate (DEPC)-treated paraformaldehyde (60 min, room temperature), washed in DEPC-treated PBS, and stored in 70% ethanol until sectioning. Additional biopsies were suspended in OCT (10.24% polyvinyl alcohol and 4.26% polyethylene glycol compound; Tissue-Tek, Torrance, CA) and frozen in liquid nitrogen. Quantitation of signal intensity. Pixel intensity was quantitated by laser scanning confocal microscopy [32, 33] . Sections hybridized with sense or antisense cRNA probes were imaged with an MRC-600 laser scanning confocal microscope (Bio-Rad Laboratories, Richmond, CA). Areas of suspected hybridization were localized by light microscopy and then confirmed by laser scanning confocal microscopy in the reflected light mode by an observer masked to all patient data. Optical sections were taken at 0.5-mm increments. Positive hybridization was confirmed if the silver grains remained in the confocal image of the optical sections above the level of nonspecific background and if signal localized over specific cell populations rather than nonspecifically over the slide. The number of pixels was counted in 5 areas (500 mm 2 ) each from serial sections of each biopsy probed with antisense and sense probes. Biopsies were considered to be positive if the pixel number with antisense probe was significantly increased, compared with an adjacent section hybridized with sense probe ( ), and if the pattern of P р .05 pixels localized over particular cell populations. Slides were also considered to be positive if visual inspection suggested only a few positive cells and the pixel intensity for those 2-4 positive areas was more than twice background (i.e., the mean of the pixel intensity for that biopsy simultaneously probed with sense [negative control] probe). The pixel intensity for those areas also exceeded the mean pixel intensity for all biopsies probed with sense probe.
Immunohistochemistry. Immunoperoxidase stains were done on 5-mm-thick sections of frozen tissue by use of an avidin-biotin method, an automated immunostainer (Biogenex, San Ramon, CA), and polyclonal rabbit anti-human IFN-g (Genzyme, Cambridge, MA). Placenta trophoblast was used as a positive control. Slides were read independently by 2 observers masked to the clinical and in situ hybridization data. Slides were considered to be positive if signal was noted within the cytoplasm of cells above the level of nonspecific signal in tissue macrophages. Positive slides were graded from 1ϩ to 3ϩ as follows: 1ϩ, !10% of leukocytes stained; 2ϩ, 10%-20% of leukocytes stained; 3ϩ, 120% of leukocytes stained.
Statistical analysis. Pixel intensity and correlation with challenge doses were compared by t test or, if not normally distributed, Wilcoxon rank sum test. Proportions were compared by x 2 test or Fisher's exact test.
Results

Detection of IFN-g mRNA and protein.
Twenty-eight healthy volunteers experimentally challenged with C. parvum oocysts and 3 AIDS patients with naturally acquired chronic cryptosporidiosis underwent endoscopy with jejunal biopsy (table 1) . Before experimental infection, the volunteers were screened for evidence of prior C. parvum infection by serum ELISA for anti-Cryptosporidium IgG and IgM. Ten of the healthy volunteers were seropositive and 18 were seronegative. Two of the seronegative volunteers had prechallenge endoscopies only. Nineteen volunteers had only postchallenge endoscopies, and 7 had both prechallenge and postchallenge studies. Seven volunteers had 2 or 3 postchallenge endoscopies separated by at least 1 week. IFN-g mRNA was detected on postchallenge biopsies from 13 of 26 volunteers by in situ hybridization, compared with 0 of 9 biopsies from healthy volunteers obtained before experimental infection ( , x 2 P = .007 test). IFN-g mRNA was detected as numerous silver granules overlying cells in the lamina propria of both crypts and villi ( figure 1A) . In contrast, biopsies from all 3 AIDS patients were negative.
Ten biopsy tissues from 4 volunteers were examined for IFNg protein production by immunohistochemistry. For 3 specimens, the immunohistochemical stains were not interpretable because of high nonspecific binding. The 1 prechallenge biopsy and 1 postchallenge biopsy from the volunteer negative by in situ hybridization were also negative by immunohistochemistry. In contrast, IFN-g was detected in postchallenge biopsies from all 3 of the volunteers with IFN-g mRNA detected by in situ hybridization (figure 1B). Overall immunohistochemistry and in situ hybridization were concordant for 4 of 7 biopsies. Two biopsies were positive only by immunohistochemistry and 1 only by in situ hybridization. As was the case with in situ hybridization, all cells positive for IFN-g protein were confined to the lamina propria. The morphology of the positive cells suggested that they were small lymphocytes. Thus, these data show that IFN-g message was being expressed as protein in the lamina propria lymphocytes of jejunal biopsies. However, because the results were clearer, we used in situ hybridization for subsequent analyses.
Correlation of IFN-g mRNA expression with previous exposure to C. parvum. Because previous studies have shown that persons with prechallenge anti-C. parvum antibody are less susceptible to infection, IFN-g expression was compared in volunteers with or without preexisting C. parvum serum IgG (table  2) . Postchallenge biopsies from 9 of 10 seropositive volunteers had IFN-g mRNA, compared with only 4 of 16 seronegative volunteers ( , x 2 test). Similarly, among the volunteers P = .001 expressing IFN-g, 9 (69%) of 13 were seropositive before challenge. Only 1 volunteer (8%) of 13 with no IFN-g mRNA detected was seropositive ( , Fisher's exact test). These P = .001 data suggest that jejunal IFN-g is expressed preferentially in persons who have been sensitized to the parasite in the past. IFN-g expression may explain the relative resistance to infection seen in seropositive subjects.
IFN-g expression and challenge dose. Volunteers were challenged with different numbers of oocysts to develop doseresponse curves [28] [29] [30] [31] . IFN-g expression on postchallenge biopsies was compared with oocyst challenge dose. An overall association was found ( , Pearson product), showing that r = .84 the percentage of volunteers expressing IFN-g increased as challenge doses increased from р100 to 50,000 oocysts. Because seropositive volunteers were more resistant to infection, the numbers of organism needed to determine the infectious dose was nearly 2 log higher than that for seronegative volunteers [31] . Median challenge doses were 300 versus 10,000 (comparing seronegative with seropositive groups; , Wilcoxon rank P ! .05 sum test). We therefore separately analyzed biopsies from the seropositive and seronegative groups. When analyzed separately, no association was found between challenge dose and IFN-g expression for the seronegative group. Volunteers challenged with challenge doses р100 oocysts or 10,000 oocysts expressed IFN-g in only a minority of cases. Among the seropositive volunteers, IFN-g expression was seen in fewer volunteers receiving 50,000 oocysts (3/4) than in volunteers receiving either 5000 (1/1) or 10,000 oocysts (5/5). Thus, when analyzed separately, neither the seropositive nor seronegative group demonstrated an association between IFN-g expression and challenge dose. Instead, the association with challenge dose likely occurred because the seropositive volunteers, the group more likely to express IFN-g, had received a higher challenge dose.
IFN-g expression and postchallenge outcomes. Earlier studies revealed a dramatic decrease in the number of oocysts shed by volunteers on rechallenge [29] . Because IFN-g is thought to be important in the control of cryptosporidiosis, we compared oocyst excretion with IFN-g expression in postchallenge biopsies. IFN-g mRNA was detected more often in volunteers who did not shed oocysts. Among 13 volunteers whose stools were negative for oocyst excretion, 9 (69%) expressed IFN-g mRNA by in situ hybridization (6 of these were seropositive and 7 seronegative). By contrast, only 4 biopsies (30%) from 13 volunteers with detectable oocysts were IFN-g positive ( ,x 2 test). All 9 of the volunteers who produced IFN-g P ! .05 without oocyst excretion had received challenge doses above the ID 50 for the challenge isolates. By contrast, the challenge dose was significantly lower for the volunteers without oocyst excretion who did not produce IFN-g (median, 300 vs. 10,000;
, Wilcoxon rank sum test). The seropositive volunteers P ! .05 who underwent endoscopy were all challenged with doses of organisms expected to infect them all (38-380 times the ID 50 for seronegative volunteers and 2.7-27 times the ID 50 for seropositive volunteers). Nevertheless, 6 did not develop detectable oocyst excretion, and all 6 expressed IFN-g.
A trend suggested an inverse correlation between IFN-g expression and symptoms. Because the seropositive volunteers studied received a high challenge dose, only 1 remained asymptomatic. Among seronegative volunteers, IFN-g message was detected in only 1 (8%) of 13 symptomatic compared with all 3 of the asymptomatic volunteers ( , Fisher's exact test). P ! .001 Thus, at lower challenge doses, expression of IFN-g correlated with the absence of symptoms. This suggests that expression of IFN-g is part of the response preventing the development of symptoms.
Timing of IFN-g expression. We examined the proportion of patients expressing IFN-g message as a function of time after infection (figure 2). In those who were seropositive prior to challenge, IFN-g message was detected as early as the first day after infection. All 6 specimens were positive during days 
1-5 after infection (before onset of symptoms)
. Three of 4 specimens obtained during days 6-13 (near the time of symptoms and oocyst excretion) and 4 of 7 from day 14 onward were positive for IFN-g message. Thus, the initial expression of IFNg in the seropositive volunteers occurs very rapidly, suggesting that priming may have already occurred. Among seronegative volunteers, IFN-g message was detected in only 1 or 2 volunteers per time point. Thus, it is impossible to make any conclusions concerning the timing of expression in the seronegative volunteers.
Intensity of IFN-g expression. Among those with detectable message, the amount was greater in specimens from volunteers who did not have detectable oocyst excretion. Semiquantitative assessment of expression was graded as 2ϩ to 4ϩ in the seropositive volunteers without detectable oocyst excretion and 0 to 4ϩ in the seropositive volunteers with detectable oocysts. Among the seronegative volunteers, signal was 1ϩ to 3ϩ in those without symptoms or oocyst shedding and 1ϩ in the only symptomatic seronegative volunteer expressing IFN-g.
Signal intensity was quantitated by use of confocal microscopy by dividing mean pixel number per area for the antisense probe by pixel number per area of the adjacent serial section probed with sense (negative control) probe. The timing of maximal expression of IFN-g message was estimated from the median signal intensity for all biopsies from each volunteer who had detectable message on any specimen. Median signal intensity was increased from baseline by days 1-5 after challenge. Of 7 biopsies obtained between days 1 and 5 after challenge, 2 had significantly increased pixel numbers ( , t test). P ! .0001 The other 5 specimens had 2 to 4 areas with markedly increased signal, consistent with less widespread expression. Peak intensity indicating maximal message production, however, was noted later, between days 6 and 13 after challenge. Signal intensity gradually decreased after day 13. Thus, whereas the initial IFN-g signal was detected in the first few days, additional time was required for maximal expression.
Discussion
In this study, we demonstrated IFN-g mRNA and protein in jejunal biopsies after experimental human cryptosporidiosis. IFN-g was localized to the lamina propria in cells morphologically consistent with lymphocytes. We did not detect IFNg in intraepithelial lymphocytes. This differs from murine models in which intraepithelial cells are an important source of IFN-g [34] . In contrast to the volunteers, none of the AIDS patients with chronic, uncontrolled diarrhea from cryptosporidiosis had detectable levels of IFN-g message in the jejunum. This finding is consistent with other studies, which have rarely identified IFN-g in biopsies from patients with AIDS and chronic diarrhea [35, 36] . Thus, expression of IFN-g was limited to immunocompetent subjects with self-limited infection.
We previously demonstrated that prior sensitization, as measured by ELISA for antibody to C. parvum oocysts, is associated with resistance to infection after C. parvum challenge and decreased oocyst shedding among those who become infected [31] . In the current study, we note that intestinal IFN-g expression correlated with prior sensitization. Interestingly, 3 of the 4 seronegative volunteers expressing IFN-g were asymptomatic and did not shed oocysts. These persons may have had an effective T cell response that prevented parasite replication and illness without detectable serum antibody. Earlier studies demonstrated that seroconversion may require repeated infec-tions, because only 2 of 19 volunteers developed an IgG response after a primary challenge with C. parvum, versus 6 of 19 after rechallenge [29] . Thus, the volunteers who did not develop symptoms or excrete oocysts but who did produce IFNg may have been infected at some time in the past despite the absent serum antibody response. Whereas there was a superficial correlation between oocyst challenge dose and IFN-g expression, this association resulted from the differing challenge doses between seropositive and seronegative volunteers.
IFN-g mRNA was detected in the first few days after infection, as would be expected for an anamnestic response to a recall antigen. Signal intensity peaked at days 7-13 after challenge, which correlates with the time of symptoms, peak oocyst excretion, and subsequent control of infection. This is the timing expected for a response that controls the parasite burden. IFN-g message persisted for 13 weeks after challenge, beyond the period of resolution of illness and healing. Although this was unexpected, similar prolonged expression of IFN-g and other proinflammatory cytokines has been noted in the colon after human shigellosis [37] . Overall, our data strongly suggest that expression of IFN-g is part of the memory response, which decreases susceptibility to infection in seropositive persons.
Not only are seropositive volunteers less likely to become infected after a C. parvum challenge, but also those volunteers with illness are less likely to shed oocysts than are their seronegative counterparts. The current study suggests that IFN-g production may explain this observation, in that an inverse correlation was seen between the expression of IFN-g and detection of oocyst excretion. Taken together, these data suggest that in previously sensitized persons, the immune response interrupts parasite development via a mechanism(s) involving IFN-g expression.
The mechanism by which the increased expression of IFNg controls intestinal cryptosporidiosis is unknown. Studies in a variety of systems have implicated IFN-g in numerous aspects of the cellular immune system [38] . Intestinal epithelial cells express IFN-g receptors, and IFN-g directly activates intestinal epithelial cells to kill intracellular Toxoplasma [39] . IFN-g could potentially activate the epithelial cells directly or activate cytotoxic lymphocytes, which in turn might destroy infected cells to limit infection. Studies with knockout mice have demonstrated a role for the costimulatory CD40-CD40 ligand system in clearing C. parvum infection by inducing apoptosis of infected epithelial cells [40] . IFN-g up-regulates expression of CD40 on intestinal epithelial cells. CD40 ligation might then cause epithelial cell death. More rapid epithelial cell turnover might lead to clearance of infection before oocyst excretion.
Although the seronegative group received a lower challenge dose than that given to the seropositive volunteers, there was no direct correlation between challenge dose and IFN-g expression for either group. Furthermore, when seropositive and seronegative volunteers were challenged with the same dose, a greater proportion of seropositive volunteers expressed IFN-g at each dose. Thus, the amount of antigen ingested does not explain the differences in IFN-g expression.
Studies have demonstrated an important role for IFN-g in the control of murine cryptosporidiosis [12, 13, [20] [21] [22] [23] . IFN-g was detected a few days after infection, before oocyst excretion, peaked at about day 9 after infection, near the timing of peak oocyst excretion, and gradually declined afterward [24, 41] . In contrast to humans, mice develop an IFN-g response with primary infection and rarely become symptomatic [21, 22] . By contrast, humans require repeated exposures to produce IFNg. The fact that we detected IFN-g mainly after reexposure suggests that priming for IFN-g production is less efficient in human than in murine cryptosporidiosis. This may explain why human infection is associated with diarrhea not seen in murine infection.
Seronegative volunteers were more susceptible to experimental infection but, when infected, also had a self-limited illness. Surprisingly, only 1 of 13 symptomatic, seronegative volunteers had detectable IFN-g message. Our studies were not designed to detect transient expression or expression limited to focal areas of the intestines. If IFN-g expression were transient (e.g., for only 2-3 days) or at low levels, we might have missed it. For technical reasons, we did not sample the ileum, the principal site of infection. Thus, if IFN-g expression were confined to the ileum in primary infection, we would not have detected it. However, the data suggest that if local ileal IFN-g expression does occur, it is likely accompanied by expression in the jejunum as well. Thus, control of cryptosporidiosis in primary infection is unlikely to rely heavily on IFN-g.
Although IFN-g appears to be important in controlling cryptosporidiosis, it is not the only mechanism of control. BALB/ c IFN-g knockout mice limit infection, suggesting that multiple immune mechanisms are responsible [42] . In addition, when the interleukin-4 gene was inactivated, murine cryptosporidiosis was more prolonged [43] . There may also be stimulation of CD40-CD40 ligand independent of IFN-g [40] . Further studies are needed to clarify how humans clear primary infection.
In summary, expression of IFN-g mRNA and protein in the jejunal lamina propria occurs after experimental human cryptosporidiosis in normal volunteers. By contrast, AIDS patients with chronic, uncontrolled cryptosporidiosis did not express IFN-g. IFN-g was detected mainly in those with evidence of sensitization (either seropositive or with a protective immune response). Thus, it appears to be associated with the T cell memory immune response to Cryptosporidium. Furthermore, IFN-g expression was inversely correlated with oocyst excretion, suggesting that intestinal IFN-g is important in controlling parasite burden in the intestines and in resisting rechallenge. By contrast, absence of local IFN-g production may be an important cause of chronic disease in AIDS. Stimulation of intestinal IFN-g may be a critically important target for vaccines to induce protection. Treatment with or stimulation of IFN-g expression may be important for immunotherapy of cryptosporidiosis in compromised human hosts, including patients with AIDS.
